WO1999051256A3 - Use of l-glu-l-trp in the treatment of hiv infection - Google Patents
Use of l-glu-l-trp in the treatment of hiv infection Download PDFInfo
- Publication number
- WO1999051256A3 WO1999051256A3 PCT/US1999/007297 US9907297W WO9951256A3 WO 1999051256 A3 WO1999051256 A3 WO 1999051256A3 US 9907297 W US9907297 W US 9907297W WO 9951256 A3 WO9951256 A3 WO 9951256A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- trp
- glu
- treatment
- hiv infection
- xaa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002326760A CA2326760A1 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
AU34667/99A AU3466799A (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
EP99916320A EP1067951A2 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5509298A | 1998-04-03 | 1998-04-03 | |
US09/055,092 | 1998-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999051256A2 WO1999051256A2 (en) | 1999-10-14 |
WO1999051256A3 true WO1999051256A3 (en) | 1999-12-09 |
Family
ID=21995541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/007297 WO1999051256A2 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1067951A2 (en) |
AU (1) | AU3466799A (en) |
CA (1) | CA2326760A1 (en) |
WO (1) | WO1999051256A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0112969A (en) | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Method of using diketopiperazines and compositions containing them |
US7732403B2 (en) | 2003-05-15 | 2010-06-08 | Dmi Biosciences, Inc. | Treatment of T-cell mediated diseases |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
PL2766029T3 (en) | 2011-10-10 | 2020-08-24 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
WO2013055749A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
JP6231484B2 (en) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Rhinitis treatment |
CN105101965B (en) | 2013-03-15 | 2021-03-09 | 安皮奥制药股份有限公司 | Compositions for stem cell mobilization, homing, expansion and differentiation and methods of use thereof |
RU2736513C2 (en) | 2014-08-18 | 2020-11-17 | Ампио Фармасьютикалз, Инк. | Treating pathological conditions of joints |
EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
US11027287B2 (en) * | 2018-07-30 | 2021-06-08 | Metso Minerals Industries, Inc. | Gyratory crusher including a variable speed drive and control system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0423077A1 (en) * | 1989-10-05 | 1991-04-17 | POLIFARMA S.p.A. | Tripeptide compounds and their pharmaceutical use as immunomodulators |
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
-
1999
- 1999-04-02 CA CA002326760A patent/CA2326760A1/en not_active Abandoned
- 1999-04-02 AU AU34667/99A patent/AU3466799A/en not_active Abandoned
- 1999-04-02 WO PCT/US1999/007297 patent/WO1999051256A2/en not_active Application Discontinuation
- 1999-04-02 EP EP99916320A patent/EP1067951A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
EP0423077A1 (en) * | 1989-10-05 | 1991-04-17 | POLIFARMA S.p.A. | Tripeptide compounds and their pharmaceutical use as immunomodulators |
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
Non-Patent Citations (1)
Title |
---|
GILL PS ET AL: "Preliminary results of a randomized study of IM-862 nasal solution in the treatment of patients with AIDS-related Kaposi's sarcoma", BLOOD, vol. 90, no. 10, 15 November 1997 (1997-11-15), pages 135a, XP002118779 * |
Also Published As
Publication number | Publication date |
---|---|
CA2326760A1 (en) | 1999-10-14 |
AU3466799A (en) | 1999-10-25 |
WO1999051256A2 (en) | 1999-10-14 |
EP1067951A2 (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0955044A3 (en) | Method of inhibiting bacterial or fungal growth using a complexing agent | |
AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
TW371628B (en) | Composition for treating condyloma acuminata | |
SE9504077D0 (en) | Liquid absorbent article considered for single use | |
IE891798L (en) | Novel ó-glucosidase inhibitors | |
EP1273298A3 (en) | Ritonavir in combination with an additional HIV protease inhibitor for treating aids | |
AU1685499A (en) | Polypeptide, their production and use | |
ES2136723T3 (en) | USE OF N-ARYL-METHYLENE-ETHYL-DIAMINE-TRIACETATES, N-ARYL-METHYLENE-IMINO-DIACETATES OR N, N'-DIARYL-METHYLENE-DIAMINE-ACETATES AGAINST OXIDIZING STRESS. | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
WO1999051256A3 (en) | Use of l-glu-l-trp in the treatment of hiv infection | |
HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
BR9811298A (en) | Use of a physiologically acceptable vanadium compound | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
TW327171B (en) | 2-heteroaryl-5 for prevention or treatment of HIV infection | |
MY124071A (en) | Treatment of viral disease in swine | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
EP0385909A3 (en) | A kit or composition for the prevention or treatment of HIV-1 infections | |
MD980129A (en) | Antiherpetic remedy | |
WO1998044913A3 (en) | Compositions containing mkc-442 in combination with other antiviral agents | |
AU6877587A (en) | Expellants of phytopathogenic microbes | |
AU1031497A (en) | Dithiazoldioxides and the use thereof as microbicides | |
WO2000002579A3 (en) | Component b as angiogenic agent in combination with human growth factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2326760 Country of ref document: CA Ref country code: CA Ref document number: 2326760 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 34667/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999916320 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999916320 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999916320 Country of ref document: EP |